API sees profit slump


Half-year results show a 14.4% drop in reported net profit, which API says is primarily due to challenging retail conditions For the half year ending 28 February 2018, Australian Pharmaceutical Industries (API) has revealed an 8.1% decrease in underlying net profit after tax (NPAT), from $29.1 million at this time last year to $26.8 million.

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous What to see at APP
Next Medicine reforms 'good news': ASMI CEO